Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Gynecology

Free Subscription Articles published in Hum Pathol Retrieve available abstracts of 18 articles: HTML format

Single Articles

May 2025
1. ZHANG Y, Karimi SS, Requena DO, Khararjian A, et al
   Intestinal and liver involvement by endometrial stromal sarcoma: Expanding the differential diagnosis of mesenchymal tumors involving the GI tract.
   Hum Pathol. 2025;158:105784.
   PubMed     Abstract available
   
   
   March 2025
2. HE D, Jin L, Geng H, Cao L, et al
   Deep learning-based analysis of gross features for ovarian epithelial tumors classification: A tool to assist pathologists for frozen section sampling.
   Hum Pathol. 2025;157:105762.
   PubMed     Abstract available
   
   
   
3. ZHANG Z, Shi H, Shao Y, Lu B, et al
   Clinicopathologic and molecular characterization of primitive neuroectodermal tumors (PNET) in the female genital tract: a retrospective study of 8 cases.
   Hum Pathol. 2025;157:105769.
   PubMed     Abstract available
   
   
   
4. ZHENG L, Tabet G, Guo CC, Rizvi YO, et al
   Clinicopathological study of 34 cases of clear cell adenocarcinoma of the urinary tract and diagnostic value of SOX 17 in its differential diagnosis.
   Hum Pathol. 2025;157:105767.
   PubMed     Abstract available
   
   
   January 2025
5. NODA Y, Tokuyama Y, Sumita W, Kita M, et al
   Hepatocyte nuclear factor 4alpha as a sensitive marker for uterine endocervical adenocarcinomas and their precursors.
   Hum Pathol. 2025;155:105714.
   PubMed     Abstract available
   
   
   
6. SCHOOLMEESTER JK, Gupta S, Boland JM, Al Kateb H, et al
   Ovarian Epithelioid Tumor with FUS::CREM Fusion and Multilineage Protein Expression: Report of a Case in the EWSR1/FUS-CREB Tumor Spectrum.
   Hum Pathol. 2025 Jan 8:105712. doi: 10.1016/j.humpath.2024.105712.
   PubMed    
   
   
   December 2024
7. KHAEFPANAH D, Zare S, Hasteh F, Shi WJ, et al
   Characterization of gastric/gastrointestinal-like immunophenotypes in endometrial endometrioid adenocarcinomas, including endometrioid adenocarcinomas with mucinous differentiation.
   Hum Pathol. 2024;154:105707.
   PubMed     Abstract available
   
   
   
8. ZHANG Y, Ju B, Cheng R, Ding T, et al
   PD-L1 expression and immune infiltration across molecular subtypes of endometrial cancer: An integrative-analysis of molecular classification and immune subtypes.
   Hum Pathol. 2024;154:105704.
   PubMed     Abstract available
   
   
   November 2024
9. ACOSTA AM, Fletcher CDM, Sholl LM, van Leenders GJ, et al
   Fluorescence in-situ hybridization assessment of spindle cell-rich testicular sex cord stromal tumors demonstrates multiple chromosomal gains across histologic subtypes.
   Hum Pathol. 2024;153:105652.
   PubMed     Abstract available
   
   
   October 2024
10. BROUARD M, Mobarki M, Peoc'h M, Karpathiou G, et al
    SALL4 expression is very rare in endometrial endometrioid and serous carcinoma.
    Hum Pathol. 2024 Oct 24:105675. doi: 10.1016/j.humpath.2024.105675.
    PubMed    
    
    
    
11. TABET GC, Zheng L, Hosseini H, Ward J, et al
    Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases.
    Hum Pathol. 2024 Oct 24:105673. doi: 10.1016/j.humpath.2024.105673.
    PubMed     Abstract available
    
    
    
12. DASHTI NK, Swanson AA, Bentz J, Xing D, et al
    DICER1-sarcomas of GYN tract: Expanding on an emerging entity.
    Hum Pathol. 2024;152:105636.
    PubMed     Abstract available
    
    
    September 2024
13. KEENEY M, Keeney GL, Cheville JC, Gupta S, et al
    VHL-mutated papillary cystadenoma of the mesosalpinx with omental tumor deposits and immunophenotypic overlap with mesothelioma.
    Hum Pathol. 2024;151:105617.
    PubMed    
    
    
    August 2024
14. NAKAJIMA J, Yano M, Zaitsu S, Kamada K, et al
    Therapeutic indications for antibody-drug conjugates estimated from HER2 and p53 expressions in endometrial carcinoma.
    Hum Pathol. 2024 Aug 16:105649. doi: 10.1016/j.humpath.2024.105649.
    PubMed     Abstract available
    
    
    July 2024
15. ZELISSE HS, Dijk F, van Gent MDJM, Hooijer GKJ, et al
    Improving histotyping precision: the impact of immunohistochemical algorithms on epithelial ovarian cancer classification.
    Hum Pathol. 2024 Jul 29:105631. doi: 10.1016/j.humpath.2024.105631.
    PubMed     Abstract available
    
    
    May 2024
16. NAVARRO SANCHEZ JM, Finkelman BS, Tyburski H, Turner BM, et al
    Performance of HER2 DAKO HercepTest and Ventana 4B5 Immunohistochemical Assays on Detecting HER2 Gene-Amplification in Uterine Serous Carcinomas.
    Hum Pathol. 2024 May 11:S0046-8177(24)00086.
    PubMed     Abstract available
    
    
    April 2024
17. NGO C, Cotteret S, Deneche I, Kfoury M, et al
    Uterine adenosarcoma: clinical significance of histological classification and SNP array analysis.
    Hum Pathol. 2024 Apr 28:S0046-8177(24)00083.
    PubMed     Abstract available
    
    
    
18. GUPTA S, Schoolmeester JK, Cheville JC
    Expanding the Spectrum of Paratesticular Mullerian-Origin Tumors: Adenocarcinoma with Mixed Serous and Endometrioid Features and Clear Cell Carcinoma.
    Hum Pathol. 2024 Apr 27:S0046-8177(24)00060.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.